OECD AI principles: Who will implement these and how?

OECD revised its AI principles to regulate booming AI uses and harmonise global fragmentation of regulation. Some loopholes remain for AI providers, governments and businesses alike.Read more ...

Museums Switching between TikTok-length and Nuance - Currying Favour, Muddling Through, or Enligthenment

Rebecca Johnson, Chief Scientist National Museum of Natural History of the U.S. Smithsonian Institution talks about aspiring a global reach while comparing to other museums and managing tensions between goals and WIPO initiatives regarding traditional knowledge, climate change, or creationism. About winning Generation Z, compressing information into social media-length, or teaching what science “is”. Complemented by an analysis how museums fluctuate between currying favours, muddling through, and enlightenment.Read more ...

Krones: Opportunities in Emerging Markets and Managing Volatile Environments

Despite being affected by tight industry environments stock listed Krones Group is surprisingly unagitated. B2Bioworld enquired with Christoph Klenk, CEO of one of the largest beverage filling and packaging machinery companies in the world on strategies countering the current crisis and paving the path to growth. However, major risks are ahead, and success is not a foregone conclusion.Read more ...

Making Money With Data

Steering Health Data For or By?

The User as Stakeholder, Expert, Citizen, Consumer, and Patient - Thomas Szucs, Chairman of Swiss Helsana Group on putting “big data” to work in insurance and healthcare Read more ...

Managers of Disease Meet Masters of Personal Health

Ursula B. Redeker, CEO of Roche Germany, about using digital tools to tap “big health data” of users, with an introduction by B2BioworldRead more ...

Businesses

Lab Shows: Where Is the Core Community?

Eurofins: “We have some of the biggest databases in the world…”

Philanthropy re-visited: Merck’s focus on Africa

Prospecting and Monitoring Distributors in Iran

Wacker Biotech B.V.: Catching up with renovation

Bayer AG: New stakes in stem cells

Cash in Agbio and Food Markets

Moving Plant Bioscience to Climate-friendly States

Corporate Compliance: Training the paper tiger to purr, show its teeth, or jump on

Personalised Medicine: Let’s be clear what it means

Skål! GM-beer served with eco-emotions

Novartis and Stem Cells

Stem Cell Research Now and in the Future - Viewed from GSK

Merck Life Science: Make or Break Drug Discovery and Biopharma

Mapei: Outlook on Construction Chemicals

Genetic Testing à la Myriad

Apropos Promaíz Argentina

Patient-centered Precision Care

ONEX gets a bargain – KraussMaffei re-structuring

ACHEMA and / or LABVOLUTION ?

editorial headlines

Automated Valet Parking More Than Nice To Have

Hello Taxi! Do you understand me?

E-mobility and more: Resolving the Innovation Paradox

Monsanto’s agbiotech strategy

Industrial Bioscience: Solutions Marketing Never Dreamt of…

Abengoa Bioenergy: Heating up in USA to pounce Latin America and Europe

Being the Truffle Pig of Industries Worldwide

Roche Ethiopia: Build-up of an emerging market

Novartis: Adhering to Values Pays Off

Network intelligence for Lundbeck’s new drugs

No Mercy with Violators of Corporate Compliance

Novo Nordisk: Commercialising stem cells

Pfizer Embraces Regenerative Medicine

Sustainability refers to more than “green” or “bio-based”

Boehringer Ingelheim: Embryonic stem cells and animal models

MediGene Set to Implement Strategic Turnaround

Is that worth a dollar, or a million dollars?

Close-up: German National Center for Tumor Diseases